Emcure Pharmaceuticals on Monday said it saw Poviztra, its newly launched semaglutide brand, as a “long-term” opportunity in India’s fast-evolving obesity and cardiometabolic therapy market, even as price competition ...
Emcure Pharmaceuticals on Monday announced the commercial launch of Poviztra, a semaglutide injection for weight loss, across India. With this launch, Emcure becomes the first Indian company to exclusively ...